Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.
With a 2020 impact factor of 7.853, Neuropsychopharmacology (NPP) ranks 14 of 156 Psychiatry journals, 13 of 275 Pharmacology and Pharmacy journals, and 27 of 273 Neuroscience journals. The journal has a 2020 CiteScore of 11.8 In 2020, on average, articles received a first decision from NPP within 30 days (with review); manuscripts publish online in twelve days from the time they are received by production.
In 2020, NPP saw more than 2.9 million article downloads, and roughly 78,600 visits to its homepage. That year, the journal’s bimonthly podcasts, or BrainPods, generate roughly 1,122 weekly listens on topics that showcase advancements in our understanding of the brain and behavior. Check us out at www.nature.com/npp!
In view of the interdisciplinary nature of the field, particular emphasis is placed on:
studies that advance the biological bases of normal and pathological behavior
the nature, etiology and pathophysiology of neuropsychiatric disorders
biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
the basic mechanisms by which psychopharmacological agents exert their effect
Dr. William A Carlezon Jr, Ph.D.
Dr. Keri Martinowich, Ph.D.
NPP Social Media Editor
Are you receiving Neuropsychopharmacology e-alerts?
Sign up with your e-mail address to receive monthly table of contents alerts and keep informed with Neuropsychopharmacology news and announcements. Each e-alert features the latest journal commentaries, circumspectives, original research and review articles.
Alzheimer's Biomarker Study Prompts Brain Supplement Warning https://bit.ly/3Pbw2XH #Alzheimers #MentalHealthAwarenessMonth @ucsdbe @UCSDMedSchool
New paper in @npp_journal from lab of @mergezettegerke shows that inhibiting dorsal CA3 during early-stage cocaine-memory reconsolidation disrupts subsequent context-induced cocaine seeking in rats